While underpowered for efficacy, post hoc analysis of ventilation-acquired pneumonia (VAP)s showed a numerical trend towards shorter ventilation duration and faster microbiological eradication with tosatoxumab.
← all excerpts
Exploring Human Use of Monoclonal Antibodies Against Critical Bacteria: A Scoping Review of Clinical Trials.
2
—
—
The sentences
While this did not reach statistical significance, the effect size suggests a potential protective trend in colonized ICU patients.